The effects of exogenous surfactant administration on ventilation-induced inflammation in mouse models of lung injury

BMC Pulmonary Medicine

Volumn 13, Issue 1, 2013, Pages

  Puntorieri, Valeria ^a   Hiansen, Josh Q ^a   McCaig, Lynda A ^b   Yao, Li Juan ^b   Veldhuizen, Ruud A W ^a,b   Lewis, James F ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Acute lung injury; Exogenous surfactant; Mechanical ventilation; Systemic inflammation

Indexed keywords

HYDROCHLORIC ACID; INTERLEUKIN 6; LUNG SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; LUNG PERFUSION; MALE; MOUSE; NONHUMAN; PEAK INSPIRATORY FLOW; POSITIVE END EXPIRATORY PRESSURE; TIDAL VOLUME; VENTILATOR INDUCED LUNG INJURY;

ACUTE LUNG INJURY; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; EICOSANOIDS; HYDROCHLORIC ACID; INFLAMMATION; INTERLEUKIN-6; LUNG; MALE; MICE; PERMEABILITY; POSITIVE-PRESSURE RESPIRATION; PULMONARY SURFACTANTS; TOTAL LUNG CAPACITY;

EID: 84887647766     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-13-67     Document Type: Article

References (41)

1. Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta 1998, 1408(2-3):79-89.
2. Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 1997, 77(4):931-962.
3. Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993, 147(1):218-233. 10.1164/ajrccm/147.1.218, 8420422.
4. Veldhuizen RA, McCaig LA, Akino T, Lewis JF. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995, 152(6 Pt 1):1867-1871.
5. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000, 342(18):1334-1349. 10.1056/NEJM200005043421806, 10793167.
6. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 2005, 353(16):1685-1693. 10.1056/NEJMoa050333, 16236739.
7. Stapleton RD, Wang BM, Hudson LD, Rubenfeld GD, Caldwell ES, Steinberg KP. Causes and timing of death in patients with ARDS. Chest 2005, 128(2):525-532. 10.1378/chest.128.2.525, 16100134.
8. Montgomery AB, Stager MA, Carrico CJ, Hudson LD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985, 132(3):485-489.
9. Walker MG, Yao LJ, Patterson EK, Joseph MG, Cepinskas G, Veldhuizen RA, Lewis JF, Yamashita CM. The effect of tidal volume on systemic inflammation in Acid-induced lung injury. Respiration 2011, 81(4):333-342. 10.1159/000323609, 21311175.
10. Gurkan OU, O'Donnell C, Brower R, Ruckdeschel E, Becker PM. Differential effects of mechanical ventilatory strategy on lung injury and systemic organ inflammation in mice. Am J Physiol Lung Cell Mol Physiol 2003, 285(3):L710-L718.
11. Dhanireddy S, Altemeier WA, Matute-Bello G, O'Mahony DS, Glenny RW, Martin TR, Liles WC. Mechanical ventilation induces inflammation, lung injury, and extra-pulmonary organ dysfunction in experimental pneumonia. Lab Invest 2006, 86(8):790-799. 10.1038/labinvest.3700440, 16855596.
12. O'Mahony DS, Liles WC, Altemeier WA, Dhanireddy S, Frevert CW, Liggitt D, Martin TR, Matute-Bello G. Mechanical ventilation interacts with endotoxemia to induce extrapulmonary organ dysfunction. Crit Care 2006, 10(5):R136. 10.1186/cc5050, 1751060, 16995930.
13. Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, Bruno F, Slutsky AS. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999, 282(1):54-61. 10.1001/jama.282.1.54, 10404912.
14. Aspros AJ, Coto CG, Lewis JF, Veldhuizen RA. High-frequency oscillation and surfactant treatment in an acid aspiration model. Can J Physiol Pharmacol 2010, 88(1):14-20. 10.1139/Y09-096, 20130734.
15. de Anda GF V, Lachmann RA, Gommers D, Verbrugge SJ, Haitsma J, Lachmann B. Treatment of ventilation-induced lung injury with exogenous surfactant. Intensive Care Med 2001, 27(3):559-565. 10.1007/s001340000838, 11355126.
16. Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte MC, Richards GA, Rippin G, Rathgeb F, Hafner D, Taut FJ, Seeger W. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004, 351(9):884-892. 10.1056/NEJMoa033181, 15329426.
17. Spragg RG, Taut FJ, Lewis JF, Schenk P, Ruppert C, Dean N, Krell K, Karabinis A, Gunther A. Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury. Am J Respir Crit Care Med 2011, 183(8):1055-1061. 10.1164/rccm.201009-1424OC, 21148720.
18. Davidson WJ, Dorscheid D, Spragg R, Schulzer M, Mak E, Ayas NT. Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis. Crit Care 2006, 10(2):R41. 10.1186/cc4851, 1550886, 16542488.
19. Yamashita C, Forbes A, Tessolini JM, Yao LJ, Lewis JF, Veldhuizen RA. Protective effects of elevated endogenous surfactant pools to injurious mechanical ventilation. Am J Physiol Lung Cell Mol Physiol 2008, 294(4):L724-L732. 10.1152/ajplung.00389.2007, 18223160.
20. Walker MG, Tessolini JM, McCaig L, Yao LJ, Lewis JF, Veldhuizen RA. Elevated endogenous surfactant reduces inflammation in an acute lung injury model. Exp Lung Res 2009, 35(7):591-604. 10.1080/01902140902780460, 19842847.
21. Yu S, Harding PG, Smith N, Possmayer F. Bovine pulmonary surfactant: chemical composition and physical properties. Lipids 1983, 18(8):522-529. 10.1007/BF02535391, 6688646.
22. von Bethmann AN, Brasch F, Nusing R, Vogt K, Volk HD, Muller KM, Wendel A, Uhlig S. Hyperventilation induces release of cytokines from perfused mouse lung. Am J Respir Crit Care Med 1998, 157(1):263-272. 10.1164/ajrccm.157.1.9608052, 9445308.
23. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37(8):911-917. 10.1139/o59-099, 13671378.
24. Duck-Chong CG. A rapid sensitive method for determining phospholipid phosphorous involving digestion with magnesium nitrate. Lipids 1979, 14(5):492-497.
25. Vockeroth D, Gunasekara L, Amrein M, Possmayer F, Lewis JF, Veldhuizen RA. Role of cholesterol in the biophysical dysfunction of surfactant in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2010, 298(1):L117-L125. 10.1152/ajplung.00218.2009, 19897745.
26. Gunasekara L, Schoel WM, Schurch S, Amrein MW. A comparative study of mechanisms of surfactant inhibition. Biochim Biophys Acta 2008, 1778(2):433-444. 10.1016/j.bbamem.2007.10.027, 18036553.
27. Ngiam N, Peltekova V, Engelberts D, Otulakowski G, Post M, Kavanagh BP. Early growth response-1 worsens ventilator-induced lung injury by up-regulating prostanoid synthesis. Am J Respir Crit Care Med 2010, 181(9):947-956. 10.1164/rccm.200908-1297OC, 20110555.
28. Jaecklin T, Engelberts D, Otulakowski G, O'Brodovich H, Post M, Kavanagh BP. Lung-derived soluble mediators are pathogenic in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2011, 300(4):L648-L658. 10.1152/ajplung.00305.2010, 21239530.
29. Zarbock A, Singbartl K, Ley K. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 2006, 116(12):3211-3219. 10.1172/JCI29499, 1679711, 17143330.
30. Stephenson AH, Lonigro AJ, Hyers TM, Webster RO, Fowler AA. Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS. Am Rev Respir Dis 1988, 138(3):714-719. 10.1164/ajrccm/138.3.714, 2849342.
31. Auner B, Geiger EV, Henrich D, Lehnert M, Marzi I, Relja B. Circulating leukotriene B4 identifies respiratory complications after trauma. Mediators Inflamm 2012, 2012:536156. 3317019, 22529525.
32. Eun JC, Moore EE, Banerjee A, Kelher MR, Khan SY, Elzi DJ, McLaughlin NJ, Silliman CC. Leukotriene b4 and its metabolites prime the neutrophil oxidase and induce proinflammatory activation of human pulmonary microvascular endothelial cells. Shock 2011, 35(3):240-244. 10.1097/SHK.0b013e3181faceb3, 3056395, 20926984.
33. Lewis JF, Veldhuizen R. The role of exogenous surfactant in the treatment of acute lung injury. Annu Rev Physiol 2003, 65:613-642. 10.1146/annurev.physiol.65.092101.142434, 12517997.
34. Ito Y, Manwell SE, Kerr CL, Veldhuizen RA, Yao LJ, Bjarneson D, McCaig LA, Bartlett AJ, Lewis JF. Effects of ventilation strategies on the efficacy of exogenous surfactant therapy in a rabbit model of acute lung injury. Am J Respir Crit Care Med 1998, 157(1):149-155. 10.1164/ajrccm.157.1.9701073, 9445293.
35. Brackenbury AM, Puligandla PS, McCaig LA, Nikore V, Yao LJ, Veldhuizen RA, Lewis JF. Evaluation of exogenous surfactant in HCL-induced lung injury. Am J Respir Crit Care Med 2001, 163(5):1135-1142. 10.1164/ajrccm.163.5.2004049, 11316649.
36. Lewis JF, Goffin J, Yue P, McCaig LA, Bjarneson D, Veldhuizen RA. Evaluation of exogenous surfactant treatment strategies in an adult model of acute lung injury. J Appl Physiol 1996, 80(4):1156-1164.
37. Welk B, Malloy JL, Joseph M, Yao LJ, Veldhuizen AW. Surfactant treatment for ventilation-induced lung injury in rats: effects on lung compliance and cytokines. Exp Lung Res 2001, 27(6):505-520. 10.1080/019021401750414038, 11558967.
38. Rasaiah VP, Malloy JL, Lewis JF, Veldhuizen RA. Early surfactant administration protects against lung dysfunction in a mouse model of ARDS. Am J Physiol Lung Cell Mol Physiol 2003, 284(5):L783-L790.
39. The Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342(18):1301-1308. The Acute Respiratory Distress Syndrome Network.
40. Stamme C, Brasch F, von Bethmann A, Uhlig S. Effect of surfactant on ventilation-induced mediator release in isolated perfused mouse lungs. Pulm Pharmacol Ther 2002, 15(5):455-461. 10.1006/pupt.2002.0383, 12406668.
41. Truscott EA, McCaig LA, Yao LJ, Veldhuizen RA, Lewis JF. Surfactant protein-A reduces translocation of mediators from the lung into the circulation. Exp Lung Res 2010, 36(7):431-439. 10.3109/01902141003721440, 20715984.